Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
13F holders, Q3 2023
Institutional positions in Biofrontera Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 8
- −5 vs. Q2 2023
- Shares held
- 16.2K
- −778.1K (−98.0%) vs. Q2 2023
- Total value
- $142.2K
- −$270.4K (−65.5%) vs. Q2 2023
- New holders
- 3
- 0 more added
- Sold out
- 8
- 5 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BFRI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $2.61M |
| Q1 2026 | 12 | $1.94M |
| Q4 2025 | 14 | $1.33M |
| Q3 2025 | 13 | $2.39M |
| Q2 2025 | 10 | $1.45M |
| Q1 2025 | 12 | $1.18M |
| Q4 2024 | 14 | $1.97M |
| Q3 2024 | 9 | $1.43M |
| Q2 2024 | 12 | $1.05M |
| Q1 2024 | 11 | $1.67M |
| Q4 2023 | 8 | $26.2K |
| Q3 2023 | 8 | $142.2K |
| Q2 2023 | 13 | $412.7K |
| Q1 2023 | 16 | $517.9K |
| Q4 2022 | 14 | $729.4K |
| Q3 2022 | 16 | $900.0K |
| Q2 2022 | 15 | $3.01M |
| Q1 2022 | 12 | $2.66M |
| Q4 2021 | 15 | $5.29M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Biofrontera Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 10,954 | $96.1K | 0.00% | −208,098−95.0% | Reduced |
| BlackRock Inc. | 4,622 | $40.5K | 0.00% | −87,798−95.0% | Reduced |
| Advisor Group Holdings, Inc. | 609 | $5.34K | 0.00% | −13,641−95.7% | Reduced |
| Cary Street Partner Investment Advisory LLC | 25 | $219 | 0.00% | +25 | New |
| Wells Fargo & Company | 6 | $53 | 0.00% | −121−95.3% | Reduced |
| JPMorgan Chase & Co | 1 | $9 | 0.00% | +1 | New |
| UBS Group AG | 1 | $9 | 0.00% | +1 | New |
| Royal Bank of Canada | 11 | $0 | 0.00% | −198−94.7% | Reduced |
| Bard Associates Inc | 0 | $0 | 0.00% | −191,200−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −88,500−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −81,282−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −50,434−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −22,900−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −20,728−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −13,109−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |